Advanced search×

Modifications of p53 and the DNA damage response in cells expressing mutant form of the protein huntingtin.

J Mol Neurosci 45(2):256-68 (2011) PMID 21465263

Huntington's disease (HD) occurs through an expansion of the trinucleotide repeat in the HD gene resulting in the lengthening of the polyglutamine stretch within the N terminus of the protein, huntingtin (Htt). While the function of the protein is still being fully elucidated, we have shown that genomic DNA damage is associated with the expression of mutant Htt (mHtt) in a time-dependent fashion. With the accumulation of mHtt and its development into a micro-aggregated complex, the initiation of genomic damage engages a cellular stress signal that activates the DNA damage and stress response pathway. Here we explore the modifications and activation of p53 and keystone regulators of the cell stress response pathway using expression of a fragment of mHtt in HEK293T cells. We find an increase in phosphorylated p53 at serine 15 (S15), diminished acetylation at lysine 382 (K382), altered ubiquitination pattern, and oligomerization activity as a function of mHtt expression. As one might predict, upstream regulators of p53, such as CREB-binding protein/p300 and MDM2, are also seen to be affected by the expression of mHtt, albeit in different ways. These data suggest a possible relationship between p53 and the slow accumulation of DNA damage resulting from the expression of mHtt. The lack of a proper p53-mediated signaling cascade or its alteration in the presence of DNA damage may contribute to the slow progression of cellular dysfunction which is a hallmark of HD pathology.

DOI: 10.1007/s12031-011-9516-4
Version: za2963e q8za4 q8zb1 q8zca q8zdb q8zea q8zf5 q8zg1

Similar articles you may find interesting…

  1. Adeno-Associated Virus (AAV) Vectors in the CNS.

    Curr Gene Ther 11(3):181-8 (2011) PMID 21453285

  2. Functional increase of brain histaminergic signaling in Huntington's disease.

    Brain Pathol 21(4):419-27 (2011) PMID 21106039

    We assessed the mRNA levels of histidine decarboxylase (HDC) and the volume and neuron number in the hypothalamic tuberomamillary nucleus (TMN) (HD n = 8, controls n = 8). In addition, we assessed mRNA levels of histamine N-methyltransferase (HMT) and of histamine receptors (H(1) R, H(2) R and H(3)...
  3. Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo.

    Audio, Transactions of the IRE Profession... 51(9):1413-7 (2010) PMID 20720046

    We observed a profound decrease of CB1 availability throughout the gray matter of the cerebrum, cerebellum, and brain stem in HD patients, even in early disease stages. Disease burden ([number of CAG repeats in the HTT gene - 35.5] x age) was inversely correlated with CB1 availability in the prefron...